학술논문

386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S340-S341
Subject
Language
ISSN
0923-7534